Tilray Brands, Inc.

TLRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $915.5M $821.3M $788.9M $627.1M $628.4M $513.1M $210.5M $167.0M
Cost of Revenue $655.0M $580.7M $565.6M $480.2M $511.6M $389.9M $185.8M $190.5M
Gross Profit $260.4M $240.6M $223.4M $147.0M $116.8M $123.2M $24.7M $-23.5M
Gross Margin 28.4% 29.3% 28.3% 23.4% 18.6% 24.0% 11.7% -14.1%
Operating Expenses
Research & Development $361.0K $284.0K $635.0K $682.0K $1.5M $830.0K $4.4M $9.2M
SG&A Expense $203.6M $167.3M $167.4M $165.2M $162.8M $111.6M $85.9M $110.9M
Operating Income $-63.0M $-2.28B $-174.7M $-1.37B $-610.4M $-132.2M $-201.1M $-304.1M
Operating Margin -6.9% -277.9% -22.1% -218.4% -97.1% -25.8% -95.6% -182.1%
Interest Expense $29.9M $41.3M $49.3M $46.6M $39.7M $30.9M $25.6M
Pretax Income $-88.1M $-2.30B $-249.0M $-1.45B $-440.7M $-345.0M $-276.7M $-329.6M
Income Tax Expense $17.1M $-121.0M $-26.6M $-7.2M $-6.5M $-9.0M $-5.6M $-8.5M
Net Income $-121.4M $-2.19B $-245.0M $-1.45B $-476.8M $-367.4M $-271.1M $-321.2M
Net Margin -13.3% -266.3% -31.1% -231.6% -75.9% -71.6% -128.8% -192.3%
EPS (Basic) $-1.09 $-24.56 $-3.30 $-2.35 $-0.99 $-1.36 $-2.15 $-3.20
EPS (Diluted) $-1.09 $-24.56 $-3.30 $-2.35 $-0.99 $-1.36 $-2.15 $-3.20
Shares Outstanding (Basic) 111.8M 89.0M 74.3M 618.0M 481.2M 269.5M 216.2M 203.5M
Shares Outstanding (Diluted) 111.8M 89.0M 74.3M 618.0M 481.2M 269.5M 216.2M 203.5M
Dividends Per Share
← Newer Page 1 of 2 Older →